Share this SmartBrief story with a colleague
Terms and conditions
You must submit valid e-mail addresses only. Use of e-mail addresses is subject to terms of SmartBrief's privacy policy.
Read something interesting?
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Story being shared
FDA: No drug shortages reported due to coronavirus
The FDA said no pharmaceutical firms have reported a shortage of any drugs as result of the coronavirus outbreak, but the agency is closely monitoring 20 medications that are made in China or rely solely on active pharmaceutical ingredients from China. The agency also said it has reminded more than 180 manufacturers to notify the FDA of any potential supply chain disruptions. Regulatory Focus (2/25)